{"id":796987,"date":"2024-12-26T12:25:05","date_gmt":"2024-12-26T17:25:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/"},"modified":"2024-12-26T12:25:05","modified_gmt":"2024-12-26T17:25:05","slug":"tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/","title":{"rendered":"Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.<\/li>\n<li style=\"margin-bottom:8pt\">\n          <strong>Pioneering the Economics of Health<\/strong> to examine the interdependencies of the healthcare ecosystem which are often overlooked when only considering a singular silo of it.<\/li>\n<li style=\"margin-bottom:8pt\">\n          <strong>AI In Biopharma<\/strong> to highlight how AI-driven technologies can revolutionize drug discovery, accelerate development timelines, enhance patient accessibility, foster quicker innovation, and significantly reduce operating costs.<\/li>\n<li style=\"margin-bottom:8pt\">Panelists to include David Rhew (Global Chief Medical Officer and VP of Healthcare, Microsoft), Sean Tunis (Principal, Rubix Health), Peter Ehrhardt (Senior Partner, Simon-Kucher), and Poonam Alaigh (Former Acting Under Secretary for Health, U.S. Department of Veterans Affairs).<\/li>\n<\/ul>\n<p>WARREN, N.J., Dec.  26, 2024  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PQXvdJUy6bHaKMTbPzxhCA5bCv4OY3K6ifqMCAGraGeXRrHq3HfyvmHVaF_TyIJpZ_FHAQWjABbCEKWH0JZ1Fw==\" rel=\"nofollow\" target=\"_blank\">Tevogen Bio<\/a> (\u201cTevogen\u201d or \u201cTevogen Bio Holdings Inc.\u201d) (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EbKONytFB1LwvP0MyoZ9RiFxF2YE2g_6uJG00C3YQSSvs179ZPKkWMH5X4cCxA7LCyT-RdKqqPidpM0gpef4l-8Lj4C_ERXcl9-N00KKMfU=\" rel=\"nofollow\" target=\"_blank\">TVGN<\/a>), will host panel discussions at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California.<\/p>\n<p>\n        <strong>Event Details<\/strong>\n      <\/p>\n<p>\n        <strong>Date:<\/strong><br \/>\n        <br \/>Monday, January 13, 2025<\/p>\n<p>\n        <strong>Location:<\/strong><br \/>\n        <br \/>Marines&#8217; Memorial Club &amp; Hotel, 609 Sutter St., San Francisco, CA 94102<\/p>\n<p>\n        <strong>Time (PST):<\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>2:00 PM \u2013 2:30 PM \u2013 AI in Biopharma: Next Frontier of Medical Innovation<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Panelists:<br \/>Dr. David Rhew \u2013 Global Chief Medical Officer and VP of Healthcare, Microsoft (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i0NvUsB1thVz_3e3TxPK9QL5vi49cQ7v9kmOhXnkNof9Qy7-jTfF6IwOuONODIMKoXdQVS94YHLCY5ChbBT1I1-QTbuciAUJNTD97Srxhqk=\" rel=\"nofollow\" target=\"_blank\">MSFT<\/a>)<br \/>Dr. Sean Tunis \u2013 Principal, Rubix Health<br \/>Mittul Mehta \u2013 Chief Information Officer and Head of Tevogen.AI, Tevogen Bio<\/p>\n<p>\n        <strong><br \/>\n          <em>2:30 pm \u2013 3:15 pm \u2013 Afternoon Coffee Break<\/em><br \/>\n        <\/strong><br \/>\n        \n      <\/p>\n<p>\n        <strong><br \/>\n          <em>3:15 PM \u2013 4:00 PM \u2013 Pioneering the Economics of Health: Balancing Access and Outcomes<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Victor Sordillo \u2013 MD, Risk Advisory Services, Verita CSG, Inc; Member, Board of Directors, Tevogen Bio<br \/>Peter Ehrhardt \u2013 Senior Partner at Simon-Kucher &amp; Partners<br \/>Dr. Poonam Alaigh \u2013 Former Acting Under Secretary for Health, U.S. Department of Veterans Affairs; Former Commissioner, New Jersey Department of Health<br \/>Dr. Sean Tunis &#8211; Principal, Rubix Health; Senior Fellow, Tufts Center for Evaluation of Value and Risk in Health; Venture Mentor, Johns Hopkins Tech Ventures<br \/>Dr. Ryan Saadi \u2013 Founder and CEO, Tevogen Bio<\/p>\n<p>\n        <strong><br \/>\n          <em>4:00 PM \u2013 6:00 PM \u2013 Reception and Cocktails<\/em><br \/>\n        <\/strong>\n      <\/p>\n<p>For inquiries regarding additional event details, please contact communications@tevogen.com.<\/p>\n<p>\n        <strong>About Tevogen Bio<\/strong>\n      <\/p>\n<p>Tevogen is a clinical-stage specialty immunotherapy company harnessing one of nature\u2019s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the significant unmet needs of large patient populations. Tevogen Leadership believes that sustainability and commercial success in the current era of healthcare rely on ensuring patient accessibility through advanced science and innovative business models. Tevogen has reported positive safety data from its proof-of-concept clinical trial, and its key intellectual property assets are wholly owned by the company, not subject to any third-party licensing agreements. These assets include three granted patents, nine pending US and twelve ex-US pending patents, two of which are related to artificial intelligence.<\/p>\n<p>Tevogen is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen\u2019s leadership believes that accessible personalized therapeutics are the next frontier of medicine, and that disruptive business models are required to sustain medical innovation.<\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>Tevogen Bio Communications<br \/>T: 1 877 TEVOGEN, Ext 701 <br \/>Communications@Tevogen.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNDE4MiM2NjcxNzI5IzIyODk5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTMyNDUyNGItYTRhZC00NWFhLWJmZmYtMDk4MjIxMDc1YmViLTEzMDE0Njc=\/tiny\/Tevogen-Bio-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. Pioneering the Economics of Health to examine the interdependencies of the healthcare ecosystem which are often overlooked when only considering a singular silo of it. AI In Biopharma to highlight how AI-driven technologies can revolutionize drug discovery, accelerate development timelines, enhance patient accessibility, foster quicker innovation, and significantly reduce operating costs. Panelists to include David Rhew (Global Chief Medical Officer and VP of Healthcare, Microsoft), Sean Tunis (Principal, Rubix Health), Peter Ehrhardt (Senior Partner, Simon-Kucher), and Poonam Alaigh (Former Acting Under Secretary for Health, U.S. Department &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-796987","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. Pioneering the Economics of Health to examine the interdependencies of the healthcare ecosystem which are often overlooked when only considering a singular silo of it. AI In Biopharma to highlight how AI-driven technologies can revolutionize drug discovery, accelerate development timelines, enhance patient accessibility, foster quicker innovation, and significantly reduce operating costs. Panelists to include David Rhew (Global Chief Medical Officer and VP of Healthcare, Microsoft), Sean Tunis (Principal, Rubix Health), Peter Ehrhardt (Senior Partner, Simon-Kucher), and Poonam Alaigh (Former Acting Under Secretary for Health, U.S. Department &hellip; Continue reading &quot;Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-26T17:25:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNDE4MiM2NjcxNzI5IzIyODk5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference\",\"datePublished\":\"2024-12-26T17:25:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/\"},\"wordCount\":541,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNDE4MiM2NjcxNzI5IzIyODk5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/\",\"name\":\"Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNDE4MiM2NjcxNzI5IzIyODk5MTc=\",\"datePublished\":\"2024-12-26T17:25:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNDE4MiM2NjcxNzI5IzIyODk5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNDE4MiM2NjcxNzI5IzIyODk5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/","og_locale":"en_US","og_type":"article","og_title":"Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference - Market Newsdesk","og_description":"The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. Pioneering the Economics of Health to examine the interdependencies of the healthcare ecosystem which are often overlooked when only considering a singular silo of it. AI In Biopharma to highlight how AI-driven technologies can revolutionize drug discovery, accelerate development timelines, enhance patient accessibility, foster quicker innovation, and significantly reduce operating costs. Panelists to include David Rhew (Global Chief Medical Officer and VP of Healthcare, Microsoft), Sean Tunis (Principal, Rubix Health), Peter Ehrhardt (Senior Partner, Simon-Kucher), and Poonam Alaigh (Former Acting Under Secretary for Health, U.S. Department &hellip; Continue reading \"Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-26T17:25:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNDE4MiM2NjcxNzI5IzIyODk5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference","datePublished":"2024-12-26T17:25:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/"},"wordCount":541,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNDE4MiM2NjcxNzI5IzIyODk5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/","name":"Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNDE4MiM2NjcxNzI5IzIyODk5MTc=","datePublished":"2024-12-26T17:25:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNDE4MiM2NjcxNzI5IzIyODk5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNDE4MiM2NjcxNzI5IzIyODk5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-discussions-ai-in-biopharma-next-frontier-of-medical-innovation-and-pioneering-the-economics-of-health-balancing-access-and-outcomes-dur\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tevogen Bio to Host Panel Discussions \u201cAI In Biopharma: Next Frontier of Medical Innovation\u201d and \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During J.P. Morgan Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/796987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=796987"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/796987\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=796987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=796987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=796987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}